RAP 0.00% 20.5¢ resapp health limited

Ann: Clinical Study of COPD Screening in Indigenous Australians, page-4

  1. 4,764 Posts.
    lightbulb Created with Sketch. 2341
    This is awesome. Once the trial is complete – and I am confident that the results will be very strong – this will be an opportunity for ResappDx to demonstrate it's value in a regional/remote setting.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.